CAMK2A and breast carcinoma: In another study, expression and phosphorylation of CaMK2α at T286 were significantly elevated in breast cancer specimens and lymph node metastasis tissues, and pharmacological inhibition of CaMK2α using both AIP and KN-93 attenuated migration and invasion of MDA-MB-231 cells [31].